Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
More news
- Health care a major election issue as B.C. doctor says he’s hit breaking point
- Navy, Lagos LG seek collaboration to curb drug, human trafficking
- Muere Saúl Blanch, primera voz de Rata Blanca; estaba hospitalizado
- ‘Landmark moment’: Sydney scientist’s world-first cancer breakthrough revealed
- Recém-nascida é encontrada em lixeira de hospital municipal em MT